Kiltearn Partners’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-349,500
| Closed | -$24.8M | – | 32 |
|
|
2022
Q3 | $24.8M | Sell |
349,500
-58,700
| -14% | -$4.17M | 1.44% | 29 |
|
|
2022
Q2 | $31.4M | Sell |
408,200
-146,300
| -26% | -$11.3M | 1.65% | 30 |
|
|
2022
Q1 | $40.5M | Sell |
554,500
-1,900
| -0.3% | -$139K | 1.74% | 28 |
|
|
2021
Q4 | $34.7M | Sell |
556,400
-20,000
| -3% | -$1.25M | 1.43% | 29 |
|
|
2021
Q3 | $34.1M | Sell |
576,400
-11,100
| -2% | -$657K | 1.41% | 29 |
|
|
2021
Q2 | $39.3M | Buy |
+587,500
| New | +$39.3M | 1.57% | 26 |
|